Skip to main content
. 2006 Dec 7;109(6):2538–2544. doi: 10.1182/blood-2006-08-038661

Table 2.

Effect of monomeric gp120 on CD4+ T-cell proliferation

No Env IIIB gp120 SF162 gp120
CD4+ cells undergoing proliferation, % 15.3 14.4 12.5
CD4 cells undergoing proliferation, % 7.7 7.4 7.3

Anti-CD3 mAb (0.5 μg/mL) stimulated CFSE-labeled PBMCs were exposed to 2 μg/mL IIIB or SF162 gp120 or left untreated. CD4+ T cells were monitored for proliferation 4 days after coculture by flow cytometry and expressed as percentage of total CD4+ T cells.